Here's how NATURE.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NATURE . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Nature.com Make Money
  6. How Much Does Nature.com Make
  7. Keywords
  8. Topics
  9. Questions
  10. Schema
  11. Social Networks
  12. External Links
  13. Analytics And Tracking
  14. Libraries
  15. Hosting Providers
  16. CDN Services

We are analyzing https://www.nature.com/articles/s41584-020-0480-7.

Title:
New insights into the role of antinuclear antibodies in systemic lupus erythematosus | Nature Reviews Rheumatology
Description:
Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease characterized by antinuclear antibodies (ANAs) that form immune complexes that mediate pathogenesis by tissue deposition or cytokine induction. Some ANAs bind DNA or associated nucleosome proteins, whereas other ANAs bind protein components of complexes of RNA and RNA-binding proteins (RBPs). Levels of anti-DNA antibodies can fluctuate widely, unlike those of anti-RBP antibodies, which tend to be stable. Because anti-DNA antibody levels can reflect disease activity, repeat testing is common; by contrast, a single anti-RBP antibody determination is thought to suffice for clinical purposes. Experience from clinical trials of novel therapies has provided a new perspective on ANA expression during disease, as many patients with SLE are ANA negative at screening despite previously testing positive. Because trial results suggest that patients who are ANA negative might not respond to certain agents, screening strategies now involve ANA and anti-DNA antibody testing to identify patients with so-called ‘active, autoantibody-positive SLE’. Evidence suggests that ANA responses can decrease over time because of the natural history of disease or the effects of therapy. Together, these findings suggest that, during established disease, more regular serological testing could illuminate changes relevant to pathogenesis and disease status. Antinuclear antibodies (ANAs), characteristic features of systemic lupus erythematosus (SLE), are a requirement for disease classification and trial enrolment. In this Review, the authors re-examine the role of ANAs in SLE and discuss changing attitudes towards using ANAs as biomarkers.
Website Age:
30 years and 10 months (reg. 1994-08-11).

Matching Content Categories {📚}

  • Education
  • Science
  • Health & Fitness

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌆 Monumental Traffic: 20M - 50M visitors per month


Based on our best estimate, this website will receive around 41,360,422 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {💰}


Display Ads {🎯}

$521,200 per month
Our analysis indicates Nature.com generates between $347,470 and $955,541 monthly online from display ads.

Keywords {🔍}

pubmed, google, scholar, article, cas, lupus, systemic, erythematosus, central, antibodies, arthritis, patients, rheum, nature, disease, immunol, antibody, rheumatol, autoantibodies, rev, clinical, antinuclear, sle, nat, pisetsky, clin, med, rheumatology, dna, ann, complexes, cell, dis, autoantibody, immune, access, role, antidna, activity, content, review, levels, testing, reviews, lipsky, autoimmune, ana, classification, res, exp,

Topics {✒️}

medical research service nature portfolio journals permissions reprints nature portfolio privacy policy autoimmune disease research mrl/mp-lpr/lpr mice advertising author correspondence disease activity index author information authors social media anti-double-stranded dna levels anti-double-stranded dna antibodies nature+ nature cyclic gmp-amp synthase anti-double-stranded dna computer-assisted pattern recognition understanding b-cell activation nucleic acid-sensing receptors interferon-alpha pathway identifies b-cell immunomics approach endogenous ifn-alpha inducer high-throughput multiplexed serology vaccine development multi-ethnic lupus cohort anti-dna antibody levels cell-derived plasma microparticles anti-dna antibody testing anti-nuclear antibody testing drug-induced lupus serum interferon-alpha activity dna/anti-dna complexes permissions anti-dsdna autoantibody levels double-stranded dna diagnostic data springerlink instant access nucleic acid-driven inflammation personal data development autoimmune mrl mice rheumatology classification criteria cell-intrinsic tlr9 expression rna-binding proteins systematic literature review late apoptotic cells african-american sle patients content diagnostic role

Questions {❓}

  • Antinuclear antibody testing: misunderstood or misbegotten?
  • Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus?
  • Systemic lupus erythematosus and dysbiosis in the microbiome: cause or effect or both?
  • Which B-cell subset should we target in lupus?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:New insights into the role of antinuclear antibodies in systemic lupus erythematosus
         description:Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease characterized by antinuclear antibodies (ANAs) that form immune complexes that mediate pathogenesis by tissue deposition or cytokine induction. Some ANAs bind DNA or associated nucleosome proteins, whereas other ANAs bind protein components of complexes of RNA and RNA-binding proteins (RBPs). Levels of anti-DNA antibodies can fluctuate widely, unlike those of anti-RBP antibodies, which tend to be stable. Because anti-DNA antibody levels can reflect disease activity, repeat testing is common; by contrast, a single anti-RBP antibody determination is thought to suffice for clinical purposes. Experience from clinical trials of novel therapies has provided a new perspective on ANA expression during disease, as many patients with SLE are ANA negative at screening despite previously testing positive. Because trial results suggest that patients who are ANA negative might not respond to certain agents, screening strategies now involve ANA and anti-DNA antibody testing to identify patients with so-called ‘active, autoantibody-positive SLE’. Evidence suggests that ANA responses can decrease over time because of the natural history of disease or the effects of therapy. Together, these findings suggest that, during established disease, more regular serological testing could illuminate changes relevant to pathogenesis and disease status. Antinuclear antibodies (ANAs), characteristic features of systemic lupus erythematosus (SLE), are a requirement for disease classification and trial enrolment. In this Review, the authors re-examine the role of ANAs in SLE and discuss changing attitudes towards using ANAs as biomarkers.
         datePublished:2020-09-03T00:00:00Z
         dateModified:2020-09-03T00:00:00Z
         pageStart:565
         pageEnd:579
         sameAs:https://doi.org/10.1038/s41584-020-0480-7
         keywords:
            Diagnostic markers
            Systemic lupus erythematosus
            Medicine/Public Health
            general
            Rheumatology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41584-020-0480-7/MediaObjects/41584_2020_480_Figa_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41584-020-0480-7/MediaObjects/41584_2020_480_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41584-020-0480-7/MediaObjects/41584_2020_480_Fig2_HTML.png
         isPartOf:
            name:Nature Reviews Rheumatology
            issn:
               1759-4804
               1759-4790
            volumeNumber:16
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:David S. Pisetsky
               affiliation:
                     name:Duke University Medical Center and Medical Research Service, Veterans Administration Medical Center
                     address:
                        name:Departments of Medicine and Immunology, Duke University Medical Center and Medical Research Service, Veterans Administration Medical Center, Durham, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Peter E. Lipsky
               url:http://orcid.org/0000-0002-9287-1676
               affiliation:
                     name:RILITE Research Institute
                     address:
                        name:RILITE Research Institute, Charlottesville, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:New insights into the role of antinuclear antibodies in systemic lupus erythematosus
      description:Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease characterized by antinuclear antibodies (ANAs) that form immune complexes that mediate pathogenesis by tissue deposition or cytokine induction. Some ANAs bind DNA or associated nucleosome proteins, whereas other ANAs bind protein components of complexes of RNA and RNA-binding proteins (RBPs). Levels of anti-DNA antibodies can fluctuate widely, unlike those of anti-RBP antibodies, which tend to be stable. Because anti-DNA antibody levels can reflect disease activity, repeat testing is common; by contrast, a single anti-RBP antibody determination is thought to suffice for clinical purposes. Experience from clinical trials of novel therapies has provided a new perspective on ANA expression during disease, as many patients with SLE are ANA negative at screening despite previously testing positive. Because trial results suggest that patients who are ANA negative might not respond to certain agents, screening strategies now involve ANA and anti-DNA antibody testing to identify patients with so-called ‘active, autoantibody-positive SLE’. Evidence suggests that ANA responses can decrease over time because of the natural history of disease or the effects of therapy. Together, these findings suggest that, during established disease, more regular serological testing could illuminate changes relevant to pathogenesis and disease status. Antinuclear antibodies (ANAs), characteristic features of systemic lupus erythematosus (SLE), are a requirement for disease classification and trial enrolment. In this Review, the authors re-examine the role of ANAs in SLE and discuss changing attitudes towards using ANAs as biomarkers.
      datePublished:2020-09-03T00:00:00Z
      dateModified:2020-09-03T00:00:00Z
      pageStart:565
      pageEnd:579
      sameAs:https://doi.org/10.1038/s41584-020-0480-7
      keywords:
         Diagnostic markers
         Systemic lupus erythematosus
         Medicine/Public Health
         general
         Rheumatology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41584-020-0480-7/MediaObjects/41584_2020_480_Figa_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41584-020-0480-7/MediaObjects/41584_2020_480_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41584-020-0480-7/MediaObjects/41584_2020_480_Fig2_HTML.png
      isPartOf:
         name:Nature Reviews Rheumatology
         issn:
            1759-4804
            1759-4790
         volumeNumber:16
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:David S. Pisetsky
            affiliation:
                  name:Duke University Medical Center and Medical Research Service, Veterans Administration Medical Center
                  address:
                     name:Departments of Medicine and Immunology, Duke University Medical Center and Medical Research Service, Veterans Administration Medical Center, Durham, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Peter E. Lipsky
            url:http://orcid.org/0000-0002-9287-1676
            affiliation:
                  name:RILITE Research Institute
                  address:
                     name:RILITE Research Institute, Charlottesville, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Nature Reviews Rheumatology
      issn:
         1759-4804
         1759-4790
      volumeNumber:16
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Duke University Medical Center and Medical Research Service, Veterans Administration Medical Center
      address:
         name:Departments of Medicine and Immunology, Duke University Medical Center and Medical Research Service, Veterans Administration Medical Center, Durham, USA
         type:PostalAddress
      name:RILITE Research Institute
      address:
         name:RILITE Research Institute, Charlottesville, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:David S. Pisetsky
      affiliation:
            name:Duke University Medical Center and Medical Research Service, Veterans Administration Medical Center
            address:
               name:Departments of Medicine and Immunology, Duke University Medical Center and Medical Research Service, Veterans Administration Medical Center, Durham, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Peter E. Lipsky
      url:http://orcid.org/0000-0002-9287-1676
      affiliation:
            name:RILITE Research Institute
            address:
               name:RILITE Research Institute, Charlottesville, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Departments of Medicine and Immunology, Duke University Medical Center and Medical Research Service, Veterans Administration Medical Center, Durham, USA
      name:RILITE Research Institute, Charlottesville, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(458)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Foundation
  • Prism.js
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mxa-002c5801.gslb.pphosted.com
  • mxb-002c5801.gslb.pphosted.com

Name Servers:

  • pdns1.ultradns.net
  • pdns2.ultradns.net
  • pdns3.ultradns.org
  • pdns4.ultradns.org
  • pdns5.ultradns.info
  • pdns6.ultradns.co.uk

CDN Services {📦}

  • Crossref

6.93s.